Gastroenterology APC and Open Access: Why Elsevier Read & Publish Deals Won't Help You Here

This is the single most important thing to know about Gastroenterology's APC. Elsevier publishes the journal, but because the AGA owns it, the title is excluded from most Elsevier Read & Publish (also called transformative) agreements.

Here's how it works:

• Elsevier negotiates Read & Publish deals with institutions and consortia worldwide.
• These deals cover Elsevier-owned journals.
• Society-owned journals published by Elsevier (like Gastroenterology, Lancet titles, Cell Press titles) are typically excluded.
• Your institution may have an Elsevier deal that covers hundreds of journals. Gastroenterology isn't one of them.

This matters because researchers often assume that their Elsevier agreement covers everything with an Elsevier logo. It doesn't. Before choosing OA at Gastroenterology, check with your library specifically about AGA journal coverage. Don't rely on your general Elsevier agreement.

Some specific situations:

The practical consequence: most researchers who want OA in Gastroenterology pay out of pocket or from grant funds. There's no automatic coverage path for the majority of institutions.

Gastroenterology works like most hybrid journals:

1. Subscription track (default, $0): Your article is behind the paywall. Institutional subscribers and AGA members have access. After the embargo period (typically 12 months), the accepted manuscript can be deposited in a repository.
2. Gold OA track (~$4,600-$4,800): Your article is immediately free to read. You choose a Creative Commons license (CC BY or CC BY-NC-ND).

Most Gastroenterology authors choose the subscription track. AGA has roughly 16,000 members, and virtually every academic GI program subscribes. The practical readership for subscription articles is large.

Gastroenterology also publishes a significant number of invited reviews, editorials, and AGA Clinical Practice Updates. These are typically free to read regardless of the author's OA choice, because AGA treats them as educational content for members.

The AGA publishes several journals with different models:

Gastro Hep Advances is the AGA's newest journal, launched as a fully gold OA title. It's designed to absorb papers that are good science but don't reach Gastroenterology's bar. The APC is lower, and being gold OA means it's Plan S compliant by design.

Clinical Gastroenterology and Hepatology (CGH) is the more clinically focused sibling. If your paper has direct practice implications but lacks the mechanistic depth Gastroenterology expects, CGH is a strong alternative at a similar APC.

Elsevier handles APC waivers on behalf of AGA journals:

Automatic geographical waivers:

• Corresponding authors in Research4Life Group A countries (low-income nations) receive a full waiver.
• Authors in Group B countries receive a 50% reduction.

Case-by-case waivers:

• Available upon request at acceptance. Elsevier states that waiver decisions are separate from editorial decisions.
• Approval isn't guaranteed, and the process can be slow.

AGA membership:

• AGA membership doesn't directly reduce the APC. There's no member discount on publication fees.
• AGA does offer research grants and awards that can be used toward publication costs.

No automatic institutional coverage:

• As discussed, most Elsevier agreements exclude Gastroenterology. You'll need a specific AGA deal or grant funding.

For researchers at well-funded US medical centers, the expectation is that your NIH or foundation grant covers the APC if you choose OA. AGA doesn't position its waiver program as a subsidy for well-funded labs.

For NIH-funded GI research, the cheapest compliant route is the subscription track plus PubMed Central deposit after the embargo. This costs $0 in publication fees and satisfies NIH policy.

Plan S compliance requires the gold OA option with CC BY licensing. At ~$4,800, this is a real cost that your grant needs to cover. Since most institutional Elsevier deals don't cover Gastroenterology, Plan S-funded researchers should budget for this explicitly when writing grants.

Understanding what Gastroenterology publishes helps you decide whether the APC is a worthwhile investment:

• Original research in GI physiology, pathobiology, and clinical science
• Translational studies that connect basic mechanisms to clinical outcomes
• Large clinical trials and prospective cohort studies
• Technical innovations in endoscopy and GI diagnostics (selectively)
• AGA Clinical Practice Updates (invited, free to read)

The journal doesn't publish case reports, small case series, or purely descriptive studies. If your paper falls into those categories, CGH or Gastro Hep Advances are better targets.

Gastroenterology desk-rejects roughly 60-70% of submissions. The editorial bar is high, and the journal expects manuscripts to advance the field meaningfully. A study that confirms what's already known, even with a large sample, usually won't make it past the editors.

• Print color figures cost money. Online color is free, but if you want color in the print edition, Elsevier charges a per-figure fee. Most readers access the journal online, so this matters less than it used to.
• The embargo period is real. If you publish via subscription, your paper is behind the paywall for 12 months. Some funders find this acceptable. Others don't.
• Supplementary data is expected. Gastroenterology wants detailed supplementary methods, figures, and tables. Preparing these takes significant effort, especially for translational studies with both clinical and mechanistic data.
• No R&P coverage means out-of-pocket costs. Budget for the APC in your grant if you anticipate needing OA. There's no safety net of institutional coverage for most researchers.
• Reprints are extra. Physical reprints are available for a fee. Digital sharing is free through the journal's author sharing policy.

Gastroenterology's cost structure is straightforward once you accept that institutional deals won't help:

1. NIH-funded, no immediate OA mandate? Publish via subscription (free). Deposit in PMC after the embargo.
2. Plan S funder? Budget ~$4,800 for CC BY gold OA from your grant. Don't assume your Elsevier deal covers it.
3. Cost-sensitive? American Journal of Gastroenterology offers a lower APC at ~$3,500-$4,000. Gut is a similar price with some BMJ institutional coverage.
4. Hepatology-focused paper? Consider Hepatology or Journal of Hepatology instead.

The real question isn't the APC. It's whether your manuscript belongs in a journal with IF ~29 and a 60-70% desk-rejection rate. Gastroenterology expects practice-changing science or mechanistic insights that reshape how the GI community thinks about disease.

Before submitting, make sure your study design, statistical approach, and clinical framing meet the journal's standards. Run a free readiness scan to catch the issues that trigger desk rejection at this level.

For the latest fees and author guidelines, visit Gastroenterology's official author information page.